These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3176000)

  • 21. Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy.
    Schifman RB; Pindur A; Bryan JA
    Arch Pathol Lab Med; 1997 Nov; 121(11):1168-70. PubMed ID: 9372743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibacterial spectrum of an antibiotic and clinical categorization].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations.
    Andes D; Craig WA
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():10-7. PubMed ID: 16209701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
    Andes D; Anon J; Jacobs MR; Craig WA
    Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.
    Kowalski RP; Yates KA; Romanowski EG; Karenchak LM; Mah FS; Gordon YJ
    Ophthalmology; 2005 Nov; 112(11):1987. PubMed ID: 16183128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Principles of selection and use of antibacterial agents.
    Hessen MT; Kaye D
    Infect Dis Clin North Am; 1989 Sep; 3(3):479-89. PubMed ID: 2671134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIC-based dose adjustment: facts and fables.
    Mouton JW; Muller AE; Canton R; Giske CG; Kahlmeter G; Turnidge J
    J Antimicrob Chemother; 2018 Mar; 73(3):564-568. PubMed ID: 29216348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological basis of antibiotic therapy.
    Wiedemann B
    Infection; 1980; Suppl 1():6-13. PubMed ID: 7399716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of bacterial and fungal culture and sensitivity results from reptilian samples submitted to a UK laboratory.
    Cushing A; Pinborough M; Stanford M
    Vet Rec; 2011 Oct; 169(15):390. PubMed ID: 21862466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Microbiological and pharmacodynamics factors defining the clinical effect of antibiotic therapy].
    Iakovlev SV
    Antibiot Khimioter; 1999; 44(5):3-5. PubMed ID: 10483497
    [No Abstract]   [Full Text] [Related]  

  • 32. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Considerations on the sense and nonsense of sensitivity determinations for veterinary practice].
    van den Bogaard AE
    Tijdschr Diergeneeskd; 1988 Sep; 113(17):921-32. PubMed ID: 3176000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology.
    Hannan PC
    Vet Res; 2000; 31(4):373-95. PubMed ID: 10958240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.